0001104659-19-052973.txt : 20191003 0001104659-19-052973.hdr.sgml : 20191003 20191003161634 ACCESSION NUMBER: 0001104659-19-052973 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20191001 FILED AS OF DATE: 20191003 DATE AS OF CHANGE: 20191003 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Erlander Mark CENTRAL INDEX KEY: 0001651537 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35558 FILM NUMBER: 191135776 MAIL ADDRESS: STREET 1: C/O TROVAGENE, INC. STREET 2: 11055 FLINTKOTE AVENUE, SUITE A CITY: SAN DIEGO STATE: CA ZIP: 92121 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Trovagene, Inc. CENTRAL INDEX KEY: 0001213037 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 272004382 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 11055 FLINTKOTE AVENUE CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: 858-952-7570 MAIL ADDRESS: STREET 1: 11055 FLINTKOTE AVENUE CITY: SAN DIEGO STATE: CA ZIP: 92121 FORMER COMPANY: FORMER CONFORMED NAME: TrovaGene Inc. DATE OF NAME CHANGE: 20110830 FORMER COMPANY: FORMER CONFORMED NAME: XENOMICS INC DATE OF NAME CHANGE: 20040719 FORMER COMPANY: FORMER CONFORMED NAME: USED KAR PARTS INC DATE OF NAME CHANGE: 20030106 4 1 a4.xml 4 X0306 4 2019-10-01 0 0001213037 Trovagene, Inc. TROV 0001651537 Erlander Mark C/O TROVAGENE, INC. 11055 FLINTKOTE SAN DIEGO CA 92121 0 1 0 0 Chief Scientific Officer Common Stock 2019-10-01 4 M 0 1250 0 A 5999 D Common Stock 2019-10-01 4 F 0 466 0 D 5533 D Restricted Stock Units 2019-10-01 4 M 0 1250 0 D Common Stock 1250 1771 D Represents the conversion upon vesting of restricted stock units into common stock (the "Converted Common Stock"). On July 24, 2018, the reporting person was granted 7,500 restricted stock units, 1,250 of which vested on October 1, 2019. Such restricted stock units were previously reported in Table II on a Form 4 filed with the Securities and Exchange Commission on July 26, 2018. The reporting person is reporting the withholding by Trovagene, Inc. of 466 shares of common stock to satisfy the reporting person's tax withholding obligations in connection with the delivery of the Converted Common Stock to the reporting person on October l, 2019. Each restricted stock unit is the economic equivalent of one share of Trovagene, Inc. common stock. On July 24, 2018, the reporting person was granted 7,500 restricted stock units, 1,250 of which vested on October 1, 2019. The common stock into which such vested restricted stock units converted on October 1, 2019 is reported in Table I on this Form 4. /s/ Mark Erlander 2019-10-03